Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus

Open access
Kales, Helen C., Lyketsos, Constantine G., Miller, Erin M., Ballard, Clive · 2019 · International Psychogeriatrics

Abstract

ABSTRACTObjectives:Behavioral and psychological symptoms of dementia (BPSD) are nearly universal in dementia, a condition occurring in more than 40 million people worldwide. BPSD present a considerable treatment challenge for prescribers and healthcare professionals. Our purpose was to prioritize existing and emerging treatments for BPSD in Alzheimer's disease (AD) overall, as well as specifically for agitation and psychosis. DESIGN: International Delphi consensus process. Two rounds of feedback were conducted, followed by an in-person meeting to ratify the outcome of the electronic process. SETTINGS: 2015 International Psychogeriatric Association meeting. PARTICIPANTS: Expert panel comprised of 11 international members with clinical and research expertise in BPSD management. RESULTS: Consensus outcomes showed a clear preference for an escalating approach to the management of BPSD in AD commencing with the identification of underlying causes. For BPSD overall and for agitation, caregiver training, environmental adaptations, person-centered care, and tailored activities were identified as first-line approaches prior to any pharmacologic approaches. If pharmacologic strategies were needed, citalopram and analgesia were prioritized ahead of antipsychotics. In contrast, for psychosis, pharmacologic options, and in particular, risperidone, were prioritized following the assessment of underlying causes. Two tailored non-drug approaches (DICE and music therapy) were agreed upon as the most promising non-pharmacologic treatment approaches for BPSD overall and agitation, with dextromethorphan/quinidine as a promising potential pharmacologic candidate for agitation. Regarding future treatments for psychosis, the greatest priority was placed on pimavanserin. CONCLUSIONS: This international consensus panel provided clear suggestions for potential refinement of current treatment criteria and prioritization of emerging therapies.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1041610218000534

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Cited by

See all 234

Metadata

Authors
Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C.
Affiliations
  • University of Michigan (US)
  • Johns Hopkins University (US)
  • University of Exeter (GB)
Corresponding author
Kales, Helen C.
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
2019-01
Volume
31
Issue
1
Pages
83-90
ISSN
1041-6102 (ISSN-L)
OpenAlex
W2885149803
Cited by
220
References
15
Citations by year
2026: 15 · 2025: 23 · 2024: 30 · 2023: 21 · 2022: 45 · 2021: 37 · 2020: 32 · 2019: 14
FWCI
16.80
Type
journal article
Language
en
Open access
Licence
Locations
  • International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
Funders
  • University of Michigan
  • International Psychogeriatric Association
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
behavioral and psychological symptoms of dementia, Alzheimer's disease, agitation, psychosis, treatment prioritization, non-pharmacological treatment, caregiver education, person-centred care, antipsychotic drugs, citalopram, analgesia, risperidone, pimavanserin, dextromethorphan/quinidine, music therapy, environmental adaptation
MeSH terms
Alzheimer Disease, Behavioral Symptoms, Delphi Technique, Geriatric Psychiatry, Humans, International Cooperation, Music Therapy, Psychomotor Agitation, Psychotic Disorders, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. https://app.cochat.ai/papers/10.1017/s1041610218000534
The paper
Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C. (2019). Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. International Psychogeriatrics. https://doi.org/10.1017/s1041610218000534

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.